Agf Investments Inc. Sarepta Therapeutics, Inc. Transaction History

Agf Investments Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$63.15 - $90.42 $259,799 - $371,987	-4,114 Closed	0 $0
Q4 2021 Feb 01, 2022	BUY	$77.28 - $99.42 $132,457 - $170,405	1,714 Added 71.42%	4,114 $370,000
Q3 2021 Nov 10, 2021	SELL	$65.97 - $92.48 $8,048 - $11,282	-122 Reduced 4.84%	2,400 $222,000
Q2 2021 Aug 10, 2021	BUY	$69.38 - $86.75 $171,368 - $214,272	2,470 Added 4750.0%	2,522 $196,000
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $223,252 - $522,055	-3,090 Reduced 98.35%	52 $4,000
Q4 2020 Feb 08, 2021	BUY	$125.56 - $178.74 $394,509 - $561,601	3,142 New	3,142 $536,000
Q4 2019 Feb 12, 2020	SELL	$76.53 - $135.58 $3.83 Million - $6.78 Million	-50,000 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$72.81 - $156.91 $3.64 Million - $7.85 Million	50,000 New	50,000 $3.77 Million
Q1 2019 May 10, 2019	SELL	$106.67 - $151.68 $8.56 Million - $12.2 Million	-80,211 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$97.32 - $148.76 $7.81 Million - $11.9 Million	80,211 New	80,211 $8.75 Million

531

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.71B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.